Britain said on Wednesday more than 25 million people had now received a first COVID-19 vaccination, 100 days after the first person in the country
received a shot.
The government said it meant almost half the adult population had received a vaccination dose, putting it on track to have offered all those over 50 a shot by the target date of April 15.
“This latest milestone is an incredible achievement -- representing 25 million reasons to be confident for the future as we cautiously reopen society,” Prime Minister Boris Johnson said in a statement.
For more coronavirus news, visit our dedicated page.
Britain's vaccine rollout began on December 8 when Margaret Keenan, a 90-year-old grandmother, became the first person in the world to receive the Pfizer COVID-19 vaccine outside of a trial.
For all the latest headlines follow our Google News channel online or via the app.
Since then Britain has offered vaccines to priority groups, starting with the eldest and most clinically vulnerable as well as frontline health workers, before moving to younger age groups.
Health services have now vaccinated a total of 25,273,226with either the Pfizer or AstraZeneca shot, and 1,759,445 people had been given both doses of the vaccine.
Greece could demand that private doctors help COVID-19 fightGreece’s health minister said Wednesday that unless at least 200 private doctors volunteer to help the public health service’s battle against COVID-19 ... Coronavirus
UK health ministry a ‘smoking ruin’ to blame for COVID-19 failures, says PM’s ex-aidBritain’s health ministry was a “smoking ruin” last year that failed to secure adequate protective equipment and other supplies early in the COVID-19 ... World News
UK’s FM says EU threat of COVID-19 vaccine export ban breaks assurancesBritish foreign minister Dominic Raab on Wednesday said that the European Commission’s threat to ban exports of COVID-19 exports cut across previous ... Coronavirus
US plans to use real world, trial data to establish when vaccines need to be updatedUS officials plan to use data gathered from people who have already been vaccinated against COVID-19 as well as data from ongoing clinical trials ... Coronavirus